MCL
Clinical trials for MCL explained in plain language.
Never miss a new study
Get alerted when new MCL trials appear
Sign up with your email to follow new studies for MCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody drug shows promise for Hard-to-Treat lymphoma
Disease control OngoingThis trial tests an antibody called epcoritamab in 666 people with B-cell lymphoma that has come back or not responded to treatment. The drug is designed to help the immune system attack cancer cells. The study looks at safety, the right dose, and how well the drug works.
Matched conditions: MCL
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New combo tackles tough lymphoma after other treatments fail
Disease control OngoingThis pilot study tests whether combining glofitamab (an IV drug) with lenalidomide (an oral drug) is a feasible treatment for people with mantle cell lymphoma that has returned or not responded to prior therapy, including a BTK inhibitor. The study enrolls 39 adults and focuses o…
Matched conditions: MCL
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC